Delyon, J.; Vallet, A.; Bernard-Cacciarella, M.; Kuzniak, I.; Reger de Moura, C.; Louveau, B.; Jouenne, F.; Mourah, S.; Lebbé, C.; Dumaz, N.
TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro. Cancers 2023, 15, 2888.
https://doi.org/10.3390/cancers15112888
AMA Style
Delyon J, Vallet A, Bernard-Cacciarella M, Kuzniak I, Reger de Moura C, Louveau B, Jouenne F, Mourah S, Lebbé C, Dumaz N.
TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro. Cancers. 2023; 15(11):2888.
https://doi.org/10.3390/cancers15112888
Chicago/Turabian Style
Delyon, Julie, Anaïs Vallet, Mélanie Bernard-Cacciarella, Isabelle Kuzniak, Coralie Reger de Moura, Baptiste Louveau, Fanélie Jouenne, Samia Mourah, Céleste Lebbé, and Nicolas Dumaz.
2023. "TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro" Cancers 15, no. 11: 2888.
https://doi.org/10.3390/cancers15112888
APA Style
Delyon, J., Vallet, A., Bernard-Cacciarella, M., Kuzniak, I., Reger de Moura, C., Louveau, B., Jouenne, F., Mourah, S., Lebbé, C., & Dumaz, N.
(2023). TERT Expression Induces Resistance to BRAF and MEK Inhibitors in BRAF-Mutated Melanoma In Vitro. Cancers, 15(11), 2888.
https://doi.org/10.3390/cancers15112888
